Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Python in Excel makes data cleaning easier than formulas ever did—no coding background required.

Max Verstappen said a "weird" braking failure caused him to crash out in the first session of Australian Grand Prix qualifying on Saturday after the four-times world champion lost grip and slammed his ...

The 2026 Formula 1 season starts at Melbourne Park with the Australian Grand Prix on the weekend of March 6-8. Lando Norris became world champion for the first time in 2025 after finishing third at a ...

This calculation can be used for hypothesis testing in statistics Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive ...

Considered to be the pinnacle of motorsport, Formula One has amassed a huge global fanbase thanks to its enthralling mix of high-octane action and sporting drama. Merging cutting-edge technology with ...

ROI is an important measure of an investment's performance but it has some drawbacks. Andrew Beattie was part of the original editorial team at Investopedia and has spent twenty years writing on a ...